Iterum TherapeuticsITRMF
13F holders, Q2 2024 (June 30)1holders −1
0new positions
1sold out
$1.15avg. 13F price*
At the end of Q2 2024, 1 institutions reported holding Iterum Therapeutics PLC (ITRMF) in their 13F filings, down 1 from Q1 2024. 0 opened new positions and 1 sold out. The largest holder was Blue Bell Private Wealth Management, LLC ($76).
- Company
- Iterum Therapeutics PLC
- CUSIP
- G6333L101
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $59 |
All 13F filers, Q1 2024 → Q2 2024: 38 shares sold, net −38 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Blue Bell Private Wealth Management, LLC | 0.00% | No change | 66 | $76 |
"% of holder's portfolio" is ITRMF's weight in each manager's 13F, not the share of Iterum Therapeutics PLC the manager owns.